Charts

By John Vandermosten, CFA NASDAQ:BJDX Bluejay Diagnostics, Inc. (NASDAQ:BJDX) reports full year 2023 results capping a year that saw substantial interaction with the FDA determining a new trial design. The endpoint for Bluejay’s previous trial sought to determine IL-6 concentration in patients with COVID and to predict the need for mechanical ventilation. With fewer COVID cases, the endpoint

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BJDX stock results show that Bluejay Diagnostics missed analyst estimates for earnings per share the fourth quarter of 2023. The post BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023 appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Ocean Biomedical (NASDAQ:OCEA) stock rose 37.6% to $2.16 during Friday's after-market session. The company's market cap stands ...

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the ...

Gainers Tivic Health Systems (NASDAQ:TIVC) stock rose 25.9% to $1.75 during Wednesday's pre-market session. The market value of their ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the closing of its previously announced public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined of

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow ...

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share ...

Gainers Cingulate (NASDAQ:CING) shares moved upwards by 125.8% to $9.01 during Thursday's regular session. The market value of their ...

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are trading lower Thursday after the company announced the pricing of a $3.5 million ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday. Following the market opening ...

Gainers Cingulate (NASDAQ:CING) stock moved upwards by 188.5% to $11.51 during Thursday's pre-market session. The market value of their ...

ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 p

By John Vandermosten, CFA NASDAQ:BJDX Bluejay Diagnostics, Inc. (NASDAQ:BJDX) issued a press release on December 27th, 2023 informing stakeholders that the clinical study evaluating the Symphony diagnostic in sepsis patients has started. The trial has been designated SYMON: Multicenter Sy mphony IL-6 Mon itoring Sepsis ICU Study. The study has been listed on the clinicaltrials.gov website under

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow ...

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ...

Gainers Cytokinetics (NASDAQ:CYTK) stock moved upwards by 73.6% to $79.37 during Wednesday's regular session. The company's market cap ...

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up ...

This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), today announced the initiation of a multicenter clinical study to evaluate the Symphony IL-6 test in sepsis patients (the SYMON study). The Symphony System is designed to address the need for simple, reliable, rapid, near-patient testing

ACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a clinical-stage medical diagnostics company developing rapid, near-patient tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the quarter and nine months ended September 30, 2023. “Based on FDA’s feedback from the August 11, 2023, meeting, the Company focused on implementing the modifi

By John Vandermosten, CFA NASDAQ:BJDX Bluejay Diagnostics, Inc. (NASDAQ:BJDX) has presented several pieces of material news in the last months adding a new CFO to its ranks, raising capital and renegotiating its license agreement with Toray Industries, Inc. Frances Scally was added as CFO of the company on September 26th following the former CFOs departure. The company raised gross proceeds of

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday's regular session. TransCode Therapeutics's ...

Gainers Inventiva (NASDAQ:IVA) stock increased by 11.2% to $4.19 during Wednesday's after-market session. The company's market cap ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are soaring Wednesday. The price move was marked by unusually high volume. What To ...

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916. Digital Transformation Opportunities Corp. (NASDAQ: ...

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Tuesday. The Dow traded up 0.47% to ...

Gainers Fresh Tracks Therapeutics (NASDAQ:FRTX) stock increased by 49.1% to $0.86 during Tuesday's after-market session. Today's ...

By John Vandermosten, CFA NASDAQ:BJDX READ THE FULL BJDX RESEARCH REPORT 2Q:23 Financial and Operational Results Since our May initiation of Bluejay Diagnostics, Inc. (NASDAQ:BJDX), the company has regained compliance with the NASDAQ minimum bid price requirement following a reverse share split on July 24th. Bluejay is preparing to complete its pivotal trial and pursue a 510(k) FDA regulatory

ACTON, Mass., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced that it has entered into a definitive agreement for the purchase and sale of 216,000 shares of the Company’s common stock at a purchase price of $7.365 per share of common stock in a registered direct offering priced at-the-mar

ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, announced financial results for the six months ended June 30, 2023. “We continued to limit our cash burn during the quarter while executing our clinical strategy for the Symphony IL-6 test and are confident that our planned clinical and analyt

ACTON, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, announced today that on August 8, 2023, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it had regained compliance wi

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for ...

Gainers Tupperware Brands Corporation (NYSE: TUP) shares surged 53.3% to $5.40 in pre-market trading after the company announced a ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to start the day final of trading this week with an overview of the biggest pre-market stock movers on Friday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60. Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ...

U.S. stocks were lower this morning, with the Dow Jones falling over 100 points on Thursday. Following the market opening Thursday, ...

Gainers Reata Pharmaceuticals (NASDAQ:RETA) shares moved upwards by 52.1% to $165.09 during Friday's regular session. As of 13:30 EST, ...

Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday. Reata ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are flying higher on Friday. The stock has been moving higher after the company ...

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 200 points on Friday. Following the market ...

Gainers Reata Pharmaceuticals (NASDAQ:RETA) shares rose 52.2% to $165.24 during Friday's pre-market session. The market value of their ...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

ACTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-20 (the “Reverse Stock Split”), with a corresponding reduction in the number of authorized outstanding n

Gainers Ainos (NASDAQ:AIMD) shares increased by 84.9% to $1.35 during Thursday's after-market session. At the close, Ainos's trading ...

Gainers Nanobiotix (NASDAQ:NBTX) shares increased by 49.8% to $7.76 during Monday's pre-market session. The company's market cap stands ...

Gainers Prestige Wealth Inc. (NASDAQ: PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alpine Summit Energy (ALPS) stock is falling on Friday after the energy development company filed for Chapter 11 bankruptcy protection. The post Why Is Alpine Summit Energy (ALPS) Stock Down 4% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Did Elon Musk Just Trigger a New Netscape Moment? The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Imedia Brands (IMBI) stock is taking a beating on Friday after it revealed it received a new delisting notice from the Nasdaq Exchange. The post Why Is iMedia Brands (IMBI) Stock Down 13% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bluejay Diagnostics (BJDX) stock is rising higher on Friday with heavy trading despite a lack of news from the medical diagnostic company. The post Why Is Bluejay Diagnostics (BJDX) Stock Up 17% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Gorilla Technology Group Inc. (NASDAQ: GRRR) shares surged 51.7% to $3.17 in pre-market trading after the company signed a ...

By John Vandermosten, CFA NASDAQ:BJDX READ THE FULL BJDX RESEARCH REPORT INITIATING COVERAGE We are initiating coverage of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) assigning a valuation of $2.00 per share. Bluejay is a diagnostic device development company offering its Symphony product pipeline. The company is advancing a sepsis triage and monitoring system for intensive care unit (ICU), emergency

ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced an updated clinical and regulatory strategy for the Symphony IL-6 biomarker test to measure acuity in sepsis patients. The Company plans to modify the clinical trials design to evaluate Symphony IL-6 as a tool to risk stratify h

ACTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, today announced financial results for the quarter ended March 31, 2023. “Our journey continues towards realizing Bluejay’s vision of improving patient outcomes by addressing time-sensitive, life-saving needs in critical care settin